DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ( ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

According to the team’s results, the BrainGate array wired directly to motor neurons offered a “sixfold improvement” on the ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

Cancer and its associated treatments represent a multifaceted challenge that affects both the physical and psychological well-being of patients. Over the ...

Women's health experts explain why so many women have been using cycle syncing to optimize wellness at every phase of the month.

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...

The ocular hypertension market is growing due to the rising prevalence of conditions impairing aqueous humor outflow, such as scarring and inflammation, leading to elevated intraocular pressure (IOP).